Exact Sciences up on Cologuard data, but questions remain
This article was originally published in Clinica
Executive Summary
Exact Sciences’ Cologuard stool-based colorectal cancer screening test has taken a step closer to US FDA approval with publication of largely positive pivotal trial results. The study compared Cologuard with fecal immunochemical test (FIT), a commonly used non-invasive colorectal cancer screening test.